Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 793-800, December 2009

Drugs that suppress TSH or cause central hypothyroidism

  • Bryan R. Haugen, MD (Professor of Medicine and Pathology)

      Affiliations

    • Corresponding Author InformationTel.: +1 303 724 3921; Fax: +1 303 724 3920.

University of Colorado Denver, School of Medicine, Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, MS 8106, PO box 6511, Aurora, CO 80045, USA

Many different drugs affect thyroid function. Most of these drugs act at the level of the thyroid in patients with normal thyroid function, or at the level of thyroid hormone absorption or metabolism in patients requiring exogenous levothyroxine. A small subset of medications including glucocorticoids, dopamine agonists, somatostatin analogues and rexinoids affect thyroid function through suppression of TSH in the thyrotrope or hypothalamus. Fortunately, most of these medications do not cause clinically evident central hypothyroidism. A newer class of nuclear hormone receptors agonists, called rexinoids, cause clinically significant central hypothyroidism in most patients and dopamine agonists may exacerbate ‘hypothyroidism’ in patients with non-thyroidal illness. In this review, we explore mechanisms governing TSH suppression of these drugs and the clinical relevance of these effects.

Keywords: TSH, central hypothyroidism, medications, thyroid function, glucocorticoids, dopamine, somatostatin, rexinoids

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(09)00083-9

doi:10.1016/j.beem.2009.08.003

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 793-800, December 2009